Update in the Pharmacological Management of Peptic Ulcer Haemorrhage

References

• Kubba AK, Palmer KR. Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer. BJS 1996;83:461–8.
   Google Scholar
• Swain CP, Bown SG, Storey DW, Kirkham JS, Salmon PR, Northfield TC. Controlled trial of Argon laser photocoagulation in bleeding peptic ulcer. Lancet 1981;ii:1313–6.
   Google Scholar
• Vallon AG, Votton PB, Laurence BH, Armengol-Miro JR, Saloro-Uses JC. Randomised trial of endoscopic Argon laser photocoagulation in bleeding peptic ulcers. Gut 1981;22:228–33.
   Google Scholar
• Swain CP, Brown SG, Salmon PR, Kirkham JS, Northfield TC. Controlled trial of Nd-Yag laser photocoagulation for bleeding peptic ulcer. Lancet 1986;i:1113–6.
   Google Scholar
• Krejs GJ, Little KH, Westergaard H, Hamilton JK, Spady DK, Polter DE. Laser photocoagulation for the treatment of acute peptic ulcer bleeding. N Engl J Med 1987:316:1618–21.
   PubMed Web of Science ®Google Scholar
• Moreto M, Zaballa M, Ibanez S, Setien F, Figa M. Efficacy of monopolar electrocoagulation in the treatment of bleeding gastric ulcer: a controlled trial. Endoscopy 1987;19:54–6.
   Google Scholar
• Laine LA. Determination of the optimum technique for bipolar electrocoagulation treatment. Gastroenterology 1991;100:107–12.
   PubMedGoogle Scholar
• Choudari CP, Rajgopal C, Palmer KR. Comparison of endoscopic injection therapy versus heater probe in major peptic ulcer haemorrhage. Gut 1992;33:1159–61.
   Google Scholar
• Nagayama K, Tazawa J, Sakai Y, Miyasaka Y, Yu SH, Maekawa S, et al. Efficacy of endoscopic clipping for bleeding gastroduodenal ulcer: comparison with topical ethenol injection. Am J Gastroenterol 1999;94:2897–901.
   PubMedGoogle Scholar
• Isenberg G, Sivak MV. Endoscopic haemostasis: something old, new, borrowed and now blue. Gastrointest Endosc 1998;48:220–1.
   PubMedGoogle Scholar
• Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D. Endoscopic haemostasis: an effective therapy for bleeding peptic ulcers. JAMA 1990;264:294–9.
   Google Scholar
• Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute non-variceal upper gastrointestinal haemorrhage: a meta-analysis. Gastroenterology 1992;102:139–48.
   PubMed Web of Science ®Google Scholar
• Kubba AK, Choudari C, Rajgopal C, Palmer KR. The outcome of urgent surgery for major peptic ulcer haemorrhage following failed endoscopic therapy. Eur J Gastroenterol Hepatol 1996;8: 1175–8.
   PubMedGoogle Scholar
• Grosso C, Rossi A, Gambitta P, Bini M, Zanasi G, Pirone Z, et al. Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion. Scand J Gastroenterol 1995;30:872–5.
   PubMed Web of Science ®Google Scholar
• Selby NM, Kubba AK, Hawkey CJ. Acid suppression in peptic ulcer haemorrhage: a “meta-analysis”. Aliment Pharmacol Ther 2000;14: 1119–26.
   PubMedGoogle Scholar
• Langman MJS. Upper gastrointestinal bleeding: the trials of trials. Gut 1985;26:217–20.
   PubMed Web of Science ®Google Scholar
• Hasselgren G, Lind T, Lundell L, Aaland E, Efsind P, Falk A, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Scand J Gastroenterol 1997; 32:328–33.
   PubMed Web of Science ®Google Scholar
• La Brooy SJ, Misiewicz JJ, Edwards J, Smith PM, Haggie SJ, Libman L, et al. Controlled trial of cimetidine in upper gastrointestinal haemorrhage. Gut 1979;20:892–5.
   PubMed Web of Science ®Google Scholar
• Stiel D, Barnes PRH, Ruppin DC, Byth K, Heap TR. Cimetidine reduces the risk of rebleeding from duodenal ulcers displaying signs of recent haemorrhage. Scand J Gastroenterol 1984;19: 798–801.
   Google Scholar
• Kang JY, Dykes PW, Hoare A, Hawkins CF, Mills JG. Treatment of acute upper gastrointestinal bleeding with cimetidine. Scottish Med J 1977;22:297–8.
   Google Scholar
• Nowak A, Sadlinski C, Gorka Z, Nowakowska E, Rudzki J, Gibinski K. Ranitidine in the treatment of acute upper gastrointestinal haemorrhage—a comparative study (preliminary report). Hepatogastroenterology 1981;28:267–9.
   PubMedGoogle Scholar
• Dawson J, Cockel R. Ranitidine in acute gastrointestinal haemorrhage. BMJ 1982;285:476–7.
   PubMedGoogle Scholar
• Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997;336:1054–8.
   PubMed Web of Science ®Google Scholar
• Aoki T. Treatment of upper gastrointestinal bleeding with the H2-receptor antagonist famotidine. JIntMedRes 1989;17 Suppl 1:32A–40A.
   Google Scholar
• Daneshmend TK, Hawkey CJ, Langmann MJS, Logan RG, Walt RP. Omeprazole versus placebo for upper gastrointestinal bleeding: randomised double blind trial. BMJ 1992;304:143–7.
   Google Scholar
• Baltas B, Dobronte Z. Randomised prospective trial of cimetidine in the treatment of acute upper gastrointestinal haemorrhage. Acta Chirurgica Hungarica 1984;25:147–57.
   PubMedGoogle Scholar
• de Muckadell OBS, Havelund T, Harlind S, Boesby S, Snel P, Vreeburg EM, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scan J Gastroenterology 1997;32:320–7.
   PubMedGoogle Scholar
• Prassler R, Hendrich H, Barnet J, Richter G, Fleischmann R, Wienbeck M. Do proton pump inhibitors after endoscopic conrol of acute ulcer haemorrhage have an advantage of H2 receptor antagonists? Zeitschr fur Gastroenterol 1995;33:431–4.
   PubMedGoogle Scholar
• Villanueva C, Balanzo J, Torras X, Sainz S, Soriano G, Gonzalez D, et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy 1995;27:308–12.
   PubMedGoogle Scholar
• Perez Flores R, Garcia Molinero MJ, Herrero Quiros C, Blasco Colmenarejo MM, Caneiro Alcubilla E, Garcia-Rayo Somoza M, et al. The treatment of upper digestive haemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole. Rev Esp Enferm Digest 1994;86:637–41.
   Google Scholar
• Goletti O, Sidoti F, Lippolis PV, De Negri F, Cavina E. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomised, controlled trial. Ital J Gastroenterol 1994;26:72–4.
   Google Scholar
• Perez-Mateo M, Sillero C, Vazquez N, Cuesta A, Segu JL. Comparative study of sucralfate and ranitidine in the treatment of bleeding duodenal ulcer. Rev Esp Enferm Digest 1991;80:87–90.
   PubMedGoogle Scholar
• Thomson AB, Maguire T, Wensel RH, Sherbaniuk RW, Bailey RJ, Kirdeikis P. Ranitidine versus cimetidine in the management of acute upper gastrointestinal tract bleeding. J Clin Gastroenterol 1984;6:295–9.
   PubMedGoogle Scholar
• Goldfarb JP, Czaja MJ. A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers. Am J Gastroenterol 1985;80:5–7.
   PubMed Web of Science ®Google Scholar
• Cardi M, Muttilo IA, Amadori L, Barillari P, Sammartino P, Arnone F, et al. Intravenous omeprazole versus ranitidine in the treatment of haemorrhagic duodenal ulcer: a prospective, randomised study. Ann Chir 1997;51:136–9.
   PubMedGoogle Scholar
• Nowak A, Gibinski K, Sadlinski C, Gorka Z, Nowakowska E, Rudzki J. Ranitidine in acute upper gastrointestinal bleeding. Gastroenterology 1983;84:1261.
   Google Scholar
• Mohamed SA, Al Karawi MA. Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding. Hepatogastroenterology 1996;43:863–5.
   PubMedGoogle Scholar
• Arora A, Tandon RK, Acharya SK, Tandon BN. The role of sustained achlorydia in bleeding peptic ulcer. J Clin Gastroenterol 1991;13:147–53.
   PubMedGoogle Scholar
• Lanas A, Artal A, Blas J, Arroyo MT, Lopez-Zaborras J, Sainz R. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol 1995;21:103–6.
   Google Scholar
• Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized control trial. Digestion 1990;45:217–25.
   PubMed Web of Science ®Google Scholar
• Gerber JG, Payne NA. Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release. J Pharm Exp Ther 1996;279:718–23.
   PubMedGoogle Scholar
• Geoghegan J, Pappas TN. Clinical use of gut peptides. Ann Surg 1997;225:145–54.
   PubMedGoogle Scholar
• Tulassay Z, Bodnar A, Szathmari M, Papp J, Farkas I. Secretin versus cimetidine in the therapy of active bleeding from peptic gastroduodenal lesions. A prospective, randomized, doubleblind, multicentric trial. Weiner Med Wochenschr 1990;140: 361–4.
   Google Scholar
• Biggs JC, Hugh TB, Dodds AJ. Tranexamic acid and upper gastrointestinal haemorrhage—a double-blind trial. Gut 1976; 17:729–34.
   Google Scholar
• von Holstein CC, Eriksson SBS, Kallen R. Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. BMJ 1987;294:7–10.
   Google Scholar
• Kubba AK, Dallal H, Haydon GH, Hayesa PC, Palmer KR. The effect of octreotide on gastroduodenal bloodflow measured by laser doppler flowmetry in rabbits and man. Am J Gastroenterol 1999;94:10–6.
   Google Scholar
• Sonnenburg A, West C. Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver. Gut 1983;24:148.
   PubMedGoogle Scholar
• Kubba AK, MacLeod DAD. The role of octreotide in peptic ulcer heamorrhage. New J Med 1997;14:18–9.
   Google Scholar
• Christiansen J, Ottenjann R, von Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201–995 in peptic ulcer bleeding. Gastroenterology 1989;97:568–74.
   Google Scholar
• Torres AJ, Landa I, Hernandez F, Jover JM, Suarez A, Arias J, et al. Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicentre controlled trial. Br J Surg 1986;73:786–9.
   PubMed Web of Science ®Google Scholar
• Magnusson I, Ihre T, Johansson C, Seligson U, Torngren S, Uvnas-Moberg K. Randomised double-blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 1985;26:221–6.
   Google Scholar
• Baltas B, Dobronte Z. Randomised prospective trial of cimetidine in the treatment of acute upper gastrointestinal haemorrhage. Acta Chir Hung 1984;25:147–57.
   PubMedGoogle Scholar
• Kayesseh L, Gyr K, Keller U, Stadler GA, Wall M. Somatostatin and cimetidine in peptic ulcer haemorrhage. Lancet 1980;1:884–6.
   Google Scholar
• Basile M, Celi S, Parisi A, Castiglione N, Parisi S. Somatostatin in the treatment of severe upper gastrointestinal bleeding of peptic origin. Ital J Surg Sci 1984;14:31–5.
   Google Scholar
• Somerville KW, Henry DA, Davies JG, Hine KR, Hawkey CJ, Longman MJ. Somatostatin in the treatment of haematemesis and malaena. Lancet 1985;1:130–2.
   PubMed Web of Science ®Google Scholar
• Antolioni A, Gondolfo M, Rigo P. Somatostatin and cimetidine in the control of upper gastrointestinal bleeding: a multicentre trial. Hepatogastroenterology 1986;33:71–4.
   Google Scholar
• Saperas E, Pique JM, Perez-Ayusco C, Bordas JM, Teres J, Rodes J, et al. Somatostatin compared with cimetidine in the treatment of bleeding peptic ulcer without a visible vessel. Aliment Pharmacol Ther 1988;2:153–9.
   Google Scholar
• Coraggio F, Scarpato P, Spina P, Ferrentino R, Lombardi S, Bellini M, et al. Somatostatin and ranitidine in the control of stigmatic haemorrhage of the upper gastrointestinal tract. BMJ 1984;280:224.
   Google Scholar
• Basso N, Bagarini M, Braci T, Cucchiara G, Gizzonio D, Grassini G, et al Ranitidine and somatostatin. Their effects on bleeding from the alimentary tract. Arch Surg 1986;121:833–5.
   Google Scholar